OncLive® announced an addition to its vibrant Strategic Alliance Partnership program today as VCU Massey Cancer Center signed onto the program's mission to raise awareness of cancer treatment and research.
OncLive® announced an addition to its vibrant Strategic Alliance Partnership program today as VCU Massey Cancer Center signed onto the program’s mission to raise awareness of cancer treatment and research. Massey Cancer Center, based in Richmond, serves patients at multiple locations throughout Virginia.
The collaboration between OncLive’s editorial and marketing teams and Massey Cancer Center will focus on news about the center’s advances in research and treatment. Massey is particularly committed to quickly turning its research discoveries into improved cancer treatment, prevention and detection. Its research includes work around cancer cell signaling, cancer molecular genetics, developmental therapeutics, radiation biology and cancer prevention and control.
Researchers at Massey recently discovered a novel chemotherapy combination that is particularly toxic to leukemia and lymphoma cells. The center is the first in Virginia to perform next-generation DNA sequencing for precision cancer treatment and also the only one in Richmond to offer interleukin-2 therapy, which stimulates the body’s immune system to kill cancer cells, for the treatment of metastatic melanoma and metastatic renal cell carcinoma.
“OncLive’s coverage of Massey’s research will help advance the center’s commitment to putting its research discoveries into practice as soon as possible,” said Mike Hennessy Jr., president of Intellisphere Oncology and Healthcare Specialty Group, part of the Plainsboro, N.J.-based Michael J. Hennessy Associates, Inc. (MJH) family of businesses, which includes OncLive. “We’ll also be able to share news of other Massey efforts, such as its investigation into the effects of the Affordable Care Act on cancer survivors.”
VCU Massey Cancer Center is one of 68 among 1,500 total cancer centers in the United States to earn National Cancer Institute designation, which it received in 1975 to help lead and shape the country’s cancer research efforts. It’s also the largest provider of bone marrow transplants in the state of Virginia, an internationally recognized pioneer in providing palliative care for cancer patients and the chronically ill, and a leader in translating research discoveries into improved treatments and advances in cancer prevention and control. “We run one of the largest cancer clinical trial programs in Virginia,” said Dr. Gordon D. Ginder, director of VCU Massey Cancer Center. “We look forward to working with OncLive to share news about our research, the advances we make in patient care and all of our other contributions in the fight against cancer.”
VCU Massey Cancer Center joins 50 other leading cancer centers, nursing schools and physician groups around the country in partnering with OncLive.
Hennessy added, “The Strategic Alliance Partnership program serves everyone committed to fighting cancer. When we work together and share our knowledge broadly, we are better armed to improve our efforts to overcome this devastating disease.”
OncLive.com is the official website for Intellisphere’s Oncology Specialty Group, which publishes Oncology & Biotech News, OncologyLive, Oncology Nursing News and Contemporary Oncology. OncLive offers oncology professionals resources and information they need to provide the best care for their patients. Intellisphere, LLC, a leading provider of healthcare publishing, research and education, is part of the Michael J. Hennessy Associates, Inc. (MJH) family of businesses, based in Plainsboro, N.J. MJH also includes the acclaimed CURE Media Group, which combines science and humanity to make cancer understandable. Its flagship product is CURE® magazine, the largest consumer publication in the U.S. focused entirely on cancer, reaching cancer patients, cancer centers and advocacy groups. To learn more, please visit http://www.OncLive.com.
About VCU Massey Cancer Center
VCU Massey Cancer Center is among the top 4 percent of cancer centers in the country to be designated by the National Cancer Institute to be at the forefront of America’s cancer research efforts. Working with all kinds of cancers, Massey conducts every form of cancer research, including basic science, translational, clinical, social, behavioral and population sciences research; provides state-of-the-art cancer treatments and cutting-edge clinical trials; serves as a vital resource for oncology education, teaching and training; and promotes cancer prevention. Massey provides award-winning cancer care at multiple sites throughout Virginia by leading cancer sub-specialists and offers one of the largest cancer clinical trial menus as well as a statewide network that brings trials to communities across the Commonwealth. Its 1,000-plus researchers, clinicians and staff members are dedicated to improving the quality of human life by discovering, developing, delivering and teaching effective means to prevent, detect, treat and ultimately cure cancer. Visit Massey online at http://www.massey.vcu.edu or call 877-4-MASSEY for more information.
For VCU Massey Cancer Center: Jenny Owen, 804.628.2111, jrowen2(at)vcu(dot)edu
For OncLive: Becky Taylor, 609.240.6886, becky(at)btaylorpa(dot)com